Evaluation of combined gene regulatory elements for transcriptional targeting of suicide gene expression to malignant melanoma

Experimental Dermatology

Volumn 12, Issue 6, 2003, Pages 799-810

  Rothfels, Heike ^a   Paschen, Annette ^a   Schadendorf, Dirk ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Diphtheria toxin A chain; Enhancer; Herpes simplex virus thymidine kinase; Malignant melanoma; Promoter; Suicide gene therapy

Indexed keywords

DIPHTHERIA TOXIN; DIPHTHERIA TOXIN A CHAIN; GANCICLOVIR; GENE PRODUCT; MELANOMA INHIBITORY ACTIVITY FACTOR; MONOPHENOL MONOOXYGENASE; THYMIDINE KINASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; ASSAY; CANCER INHIBITION; CELL DEATH; CELL KILLING; CONTROLLED STUDY; CYTOMEGALOVIRUS; ENHANCER REGION; GENE CONSTRUCT; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE TARGETING; GENETIC CODE; GENETIC TRANSCRIPTION; HERPES SIMPLEX VIRUS; HUMAN; HUMAN CELL; MELANOCYTE; MELANOMA; MELANOMA CELL; NONHUMAN; PROMOTER REGION; REPORTER GENE; SUICIDE GENE; SUICIDE GENE THERAPY; TISSUE SPECIFICITY;

ANIMALS; CELL DEATH; CELL LINE; CELL LINE, TUMOR; CHLORAMPHENICOL O-ACETYLTRANSFERASE; COLORING AGENTS; CYTOMEGALOVIRUS; DNA; ENHANCER ELEMENTS (GENETICS); GENE EXPRESSION REGULATION, NEOPLASTIC; GENE THERAPY; GENES, REGULATOR; GENES, REPORTER; HELA CELLS; HUMANS; MELANOMA; MICE; NEOPLASM METASTASIS; PLASMIDS; PROMOTER REGIONS (GENETICS); TETRAZOLIUM SALTS; THIAZOLES; TIME FACTORS; TRANSCRIPTION, GENETIC; TRANSFECTION;

EID: 0346969827     PISSN: 09066705     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0906-6705.2003.00093.x     Document Type: Article

References (45)

1. Schadendorf D. Gene based therapies in malignant melanoma. Sem Oncol 2002: 29: 503-512.
2. Sun Y, Paschen A, Schandendorf D. Cell-based vaccination against melanoma - Background, preliminary results, and perspective. J Mol Med 1999: 77: 593-608.
3. Vile R G, Nelson J A, Castleden S, Chong H, Hart I R. Systemic gene therapy of murine melanoma using tissue specific expression of the HSVtk gene involves an immune component. Cancer Res 1994: 54: 6228-6234.
4. Vile R G, Castleden S, Marshall J, Camplejohn R, Upton C, Chong H. Generation of an anti-tumour immune response in a non-immunogenic tumour: HSVtk killing in vivo stimulates a mononuclear cell infiltrate and a Th1-like profile of intratumoural cytokine expression. Int J Cancer 1997: 71: 267-274.
5. Collier R J. Diphtheria toxin: Mode of action and structure. Bacteriol Rev 1975: 39: 54-85.
6. Pappenheimer A M Jr. Diphtheria toxin. Annu Rev Biochem 1977: 46: 69-94.
7. Kohno K, Uchida T, Ohkubo H, et al. Amino acid sequence of mammalian elongation factor 2 deduced from the cDNA sequence: Homology with GTP-binding proteins. Proc Natl Acad Sci U S A 1986: 83: 4978-4982.
8. Moehring T J, Danley D E, Moehring J M. In vitro biosynthesis of diphthamide, studied with mutant Chinese hamster ovary cells resistant to diphtheria toxin. Mol Cell Biol 1984: 4: 642-650.
9. St. Clair M H, Lambe C U, Furman P A. Inhibition by ganciclovir of cell growth and DNA synthesis of cells biochemically transformed with herpesvirus genetic information. Antimicrob Agents Chemother 1987: 31: 844-849.
10. Reid R, Mar E C, Huang E S, Topal M D. Insertion and extension of acyclic, dideoxy, and are nucleotides by herpesviridae, human alpha and human beta polymerases. A unique inhibition mechanism for 9-(1, 3-dihydroxy-2-propoxymethyl) guanine triphosphate. J Biol Chem 1988: 263: 3898-3904.
11. Culver K W, Ram Z, Wallbridge S, Ishii H, Oldfield E H, Blaese R M. In vivo gene transfer with retroviral vector-producer cells or treatment of experimental brain tumors. Science 1992: 256: 1550-1552.
12. Freeman S M, Abboud C N, Whartenby K A, et al. The 'bystander effect'": Tumor regression when a fraction of the tumor mass is geneticlly modified. Cancer Res 1993: 53: 5274-5283.
13. Moolten F L. Tumor chemosensitivity conferred by inserted herpes thymidine kinase genes: Paradigm for a prospective cancer control strategy. Cancer Res 1986: 46: 5276-5281.
14. Wei S J, Chao Y, Hung Y M, et al. S- and G2-phase cell cycle arrests and apoptosis induced by ganciclovir in murine melanoma cells transduced with herpes simplex virus thymidine kinase. Exp Cell Res 1998: 241: 66-75.
15. Alemany R, Balague C, Curiel D T. Replicative adenoviruses for cancer therapy. Nat Biotechnol 2000: 18: 723-727.
16. Siders W M, Halloran P J, Fenton R G. Melanoma-specific cytotoxicity induced by a tyrosinase promoter-enhancer/herpes simplex virus thymidine kinase adenovirus. Cancer Gene Ther 1998: 5: 281-291.
17. Hughes B W, Wells A H, Bebok Z, et al. Bystander killing of melanoma cells using the human tyrosinase promoter to express the Escherichia coli purine nucleoside phosphorylase gene. Cancer Res 1995: 55: 3339-3345.
18. Hearing V J, Jimenez M. Analysis of mammalian pigmentation at the molecular level. Pigment Cell Res 1989: 2: 75-85.
19. Beermann F, Ruppert S, Hummler E, et al. Rescue of the albino phenotype by introduction of a functional tyrosinase gne into mice. Embo J 1990: 9: 2819-2826.
20. Kluppel M, Beermann F, Ruppert S, Schmid E, Hummler E, Schutz G. The mouse tyrosinase promoter is sufficient for expression in melanocytes and in the pigmented epithelium of the retina. Proc Natl Acad Sci U S A 1991: 88: 3777-3781.
21. Tanaka S, Yamamoto H, Takeuchi S, Takeuchi T. Melanization in albino mice transformed by introducing cloned mouse tyrosinase gene. Development 1990: 108: 223-227.
22. Orlow S J, Hearing V J, Sakai C, et al. Changes in expression of putative antigens encoded by pigment genes in mouse melanomas at different stages of malignant progression. Proc Natl Acad Sci U S A 1995: 92: 10152-10156.
23. Blesch A, Bosserhoff A K, Apfel R, et al. Cloning of a novel malignant melanoma-derived growth-regulatory protein, MIA. Cancer Res 1994: 54: 5695-5701.
24. Bosseerhoff A K, Hein R, Bogdahn U, Buettner R. Structure and promoter analysis of the gene encoding the human melanoma-inhibiting protein MIA. J Biol Chem 1996; 271: 490-495.
25. Bosserhoff A K, Echtenacher B, Hein R, Buettner R. Functional role of melanoma inhibitory activity in regulating invasion and metastasis of malignant melanoma cells in vivo. Melanoma Res 2001: 11: 417-421.
26. Guba M, Bosserhoff A K, Steinbauer M, et al. Overexpression of melanoma inhibitory activity (MIA) enhances extravasation and metastasis of A-mel 3 melanoma cells in vivo. Br J Cancer 2000: 83: 1216-1222.
27. Bosserhoff A K, Buettner R. Expression, function and clinical relevance of MIA (melanoma inhibitory activity). Histol Histopathol 2002: 17: 289-300.
28. Bosserhoff A K, Kondo S, Moser M, et al. Mouse CD-RAP/MIA gene: Structure, chromosomal localization, and expression in cartilage and chondrosarcoma. Dev Dyn 1997: 208: 516-525.
29. Bosserhoff A K, Moser M, Hein R, Landthaler M, Buettner R. In situ expression patterns of melanoma-inhibiting activity (MIA) in melanomas and breast cancers. J Pathol 1999: 187: 446-454.
30. Perez R P, Zhang P, Bosserhoff A K, Buettner R, Abu-Hadid M. Expression of melanoma inhibitory activity in melanoma and nonmelanoma tissue specimens. Hum Pathol 2000: 31: 1381-1388.
31. Van Groningen J J, Bloemers H P, Swart G W. Identification of melanoma inhibitory activity and other differentially expressed messenger RNAs in human melanoma cell lines with different metastatic capacity by messenger RNA differential display. Cancer Res 1995: 55: 6237-6243.
32. Ganss R, Montoliu L, Monaghan A P, Schutz G. A cell-specific enhancer far upstream of the mouse tyrosinase gene confers high level and copy number-related expression in transgenic mice. Embo J 1994: 13: 3083-3093.
33. Artuc M, Nurnberg W, Czarnetzki B M, Schadendorf D. Characterization of gene regulatory elements for selective gene expression in human melanoma cells. Biochem Biophys Res Commun 1995: 213: 699-705.
34. Luckow B, Schutz G. CAT constructions with multiple unique restriction sites for the functional analysis of eukaryotic promoters and regulatory elements. Nucl Acids Res 1987: 15: 5490.
35. Maxwell I H, Maxwell F, Globe L M. Regulated expression of a diphtheria toxin A-chain gene transfected into human cells: Possible strategy for inducing cancer cell suicide. Cancer Res 1986; 46: 4660-4664
36. Shibata K, Muraosa Y, Tomita Y, Tagami H, Shibahara S. Identification of a cis-acting element that enhances the pigment cell-specific expression of the human tyrosinase gene. J Biol Chem 1992: 267: 20584-20588.
37. Park B J, Brown C K, Hu Y, et al. Augmentation of melanoma-specific gene expression using a tandem melanocyte-specific enhancer results in increased cytotoxicity of the purine nucleoside phosphorylase gene in melanoma. Hum Gene Ther 1999: 10: 889-898.
38. Galanis E, Vile R, Russell S J. Delivery systems intended for in vivo gene therapy of cancer: Targeting and replication competent viral vectors. Crit Rev Oncol Hematol 2001: 38: 177-192.
39. Osaki T, Tanio Y, Tachibana I, et al. Gene therapy for carcinoembryonic antigen-producing human lung cancer cells by cell type-specific expression of herpes simplex virus thymidine kinase gene. Cancer Res 1994: 54: 5258-5261.
40. Richards C A, Wolberg A S, Huber B E. The transcriptional control region of the human carcinoembryonic antigen gene: DNA sequence and homology studies. DNA Seq 1993: 4: 185-196.
41. Pang S. Targeting and eradicating cancer cells by a prostate-specific vector carrying the diphtheria toxin A gene. Cancer Gene Ther 2000: 7: 991-996.
42. Vile R G, Hart I R. Use of tissue-specific expression of the herpes simplex virus thymidine kinase gene to inhibit growth of established murine melanomas following direct intratumoral injection of DNA. Cancer Res 1993: 53: 3860-3864.
43. Siders W M, Halloran P J, Fenton R G. Transcriptional targeting of recombinant adenoviruses to human and murine melanoma cells. Cancer Res 1996: 56: 5638-5646.
44. Manome Y, Abe M, Hagen M F, Fine H A, Kufe D W. Enhancer sequences of the DF3 gene regulate expression of the herpes simplex virus thymidine kinase gene and confer sensitivity of human breast cancer cells to ganciclovir. Cancer Res 1994: 54: 5408-5413.
45. Kumagai T, Tanio Y, Osaki T, et al. Eradication of Myc-overexpressing small cell lung cancer cells transfected with herpes simplex virus thymidine kinase gene containing Myc-Max response elements. Cancer Res 1996: 56: 354-358.